Mauritius vs Saudi Arabia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Mauritius
98.0%
in 2025
Saudi Arabia
98.0%
in 2025
Mauritius rank
10th
Saudi Arabia rank
10th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Mauritius
- Saudi Arabia
How they compare
Mauritius currently reports 98.0% against 98.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Saudi Arabia ahead.
Mauritius ranks 10th and Saudi Arabia ranks 10th of 192 countries.
Saudi Arabia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.0% | 49.0% | Saudi Arabia |
| 2010s | 28.7% | 97.8% | 69.1% | Saudi Arabia |
| 2020s | 95.0% | 96.8% | 1.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Mauritius or Saudi Arabia?
- Mauritius, at 98.0% against 98.0% in Saudi Arabia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Mauritius and Saudi Arabia?
- 0.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Saudi Arabia?
- 18 years are reported by both, from 2008 to 2025.
- How do Mauritius and Saudi Arabia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mauritius ranks 10th and Saudi Arabia ranks 10th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.